The information you provide to the chat will be collected and recorded to improve your experience and for quality assurance. Please read our privacy policy to see how we are storing and protecting your data.
How can we help you today?

Hot melt extrusion: Improving solubility of poorly soluble compounds

Whitepaper

Solving solubility challenges before they become long-term issues is critical for the success of your small molecule project. One potential development and manufacturing option to address solubility challenges is implementing a hot melt extrusion (HME) strategy to manufacture amorphous solid dispersions (ASDs).

Leveraging HME solutions can result in solvent-free processing, reduced cost of goods (COGs), and continuous manufacturing. As you build out your HME strategy, there are a variety of considerations around pharmaceutical applications, formulation, and processing to ensure your strategy is flexible, robust, and comprehensive.